Trial intelligence / Profile preview

Calcium Hydroxide and Diclofenac Sodium for Post-Endodontic Pain

NCT06632015Completed

Sponsor
Hatay Mustafa Kemal University
Start
Jan 2024
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, triple-blind trial of diclofenac in apical periodontitis (AP) (3 arms), sponsored by Hatay Mustafa Kemal University. Primary endpoint: Post-Endodontic Pain Intensity at Day 7. Started Jan 2024; status: completed.

02

Drugs

diclofenac
03

Conditions

apical periodontitis (AP)

Beyond the preview

Go deeper on NCT06632015.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06632015.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call